A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 7330-7337

  Balasa, B ^a   La Cava, A ^a   Van Gunst, K ^a   Mocnik, L ^a   Balakrishna, D ^a   Nguyen, N ^a   Tucker, L ^a   Sarvetnick, N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE COURSE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; INSULITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SCID MOUSE; VASCULAR ENDOTHELIUM;

EID: 0034671626     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.7330     Document Type: Article

References (28)

1. The murine autoimmune diabetes model: NOD and related strains
2. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
3. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity
4. Transgenic expression of IL-10 in pancreatic islet α cells accelerates autoimmune insulitis and diabetes in nonobese diabetic mice
5. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing IL-10 in the islets of Langerhans
6. + T and B lymphocytes
7. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice
8. Islet-specific expression of interleukin-10 promotes diabetes in nonobese diabetic (NOD) mice independent of Fas, Perforin, TNFR-1 and TNFR-2 molecules
9. Following a diabetogenic T cell from genesis through pathogenesis
10. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice
11. Interleukin-10-deficient mice develop enterocolitis
12. IL-10-deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic (NOD) mouse
13. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice
14. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
15. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomenon in NOD mice
16. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice
17. IL-10 inhibits cytokine production by activated macrophages
18. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
19. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT): Evidence for IL-10-enhanced cell death in EAT
20. + T cells
21. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells
22. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens
23. The temporal importance of TNFα expression in the development of diabetes
24. Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells
25. + T cells
26. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen/intercellular adhesion molecule-1 pathway
27. The immunological synapse: A molecular machine controlling T cell activation
28. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells